Home Tools
Log in
Cart

Search Result

Search Results for " carbidopa "

Targets

5

Compounds

2

Natural Products

Cat No. Product Name Synonyms Targets
T2148 Carbidopa monohydrate Carbidopa Hydrate,S(-)-Carbidopa Decarboxylase , Aryl Hydrocarbon Receptor
Carbidopa monohydrate (S(-)-Carbidopa) is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.
T68937 Carbidopa hydrochloride
Carbidopa hydrochloride is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of peripheral levodopa...
T15339 Foscarbidopa Carbidopa 4′-monophosphate Dopamine Receptor
Foscarbidopa is a prodrug of Carbidopa. It acts as a dopamine receptor agonist.
T1119 Rasagiline AGN1135,TVP1012 BCL , MAO , Monoamine Oxidase
Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease.
T6708 Tolcapone Tasmar,Ro 40-7592 Apoptosis , Beta Amyloid , Transferase
Tolcapone (Ro 40-7592) is a catechol-O-methyltransferase inhibitor used in the therapy of Parkinson disease as adjunctive therapy in combination with levodopa and carbidopa.
Cat No. Product Name Synonyms Targets
T6795 Carbidopa (S)-(-)-Carbidopa,Lodosyn Decarboxylase , Aryl Hydrocarbon Receptor
Carbidopa (Lodosyn) is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
T0848 L-DOPA Levodopa,3,4-Dihydroxyphenylalanine Dopamine Receptor , Endogenous Metabolite
L-DOPA (Levodopa) is an amino acid precursor of dopamine with antiparkinsonian properties. Levodopa is a prodrug that is converted to dopamine by DOPA decarboxylase and can cross the blood-brain barrier. When in the brai...
TargetMol